MedTrace Logo

Indomethacin Prior to Difficult Embryo Transfer is it a Solution?

NCT03533803 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-12-14

No results posted yet for this study

Summary

IVF/ICSI patients who had difficult mock embryo transfer on the day of ovum pick up. Will be randomly assigned into two groups; group A will receive 100mg indomethacin rectal suppository 1-2 hours before ET and group B will not receive indomethacin

Conditions

  • Difficult Embryo Transfer

Interventions

DRUG

Indomethacin 100Mg Suppository

Indomethacin 100Mg Suppository will be given 1 to 2 hours before embryo transfer in cases with difficult mock embryo transfer in the active comparator group.

PROCEDURE

IVF/ICSI

patients received induction with the long agonist stimulation protocol. Followed by ovum pickup and embryo transfer. Only those with difficult mock embryo transfer will be recruited in this study.

Sponsors & Collaborators

  • Nile Ivf Center, Cairo, Egypt

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • Sarwat Ahawany, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-02
Primary Completion
2018-12-02
Completion
2018-12-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03533803 on ClinicalTrials.gov